Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease

ConclusionsUsing RAAS in patients with chronic kidney disease improved QALY in both diabetic and nondiabetic patients and proved to be cost-effective.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research